Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07436156 · ClinicalTrials.gov registry record · Phase 4

SUMMIT RISE Study of Acute Ischemic Stroke Patients

A Phase 4 study of Acute Ischemic Stroke, sponsored by Route 92 Medical.

Recruiting
Registry status
Phase 4
Development phase
500
Enrollment target
1
Study location

NCT07436156 is a Phase 4 study of Acute Ischemic Stroke that is actively recruiting participants, run by Route 92 Medical. The registered enrollment target is 500 participants, above the 332-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (51% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07436156, a Phase 4 study of Acute Ischemic Stroke, is actively recruiting participants, sponsored by Route 92 Medical.

RECRUITING
Registry status
Phase 4
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

SUMMIT RISE Study of Acute Ischemic Stroke Patients

Conditions Studied

Interventions

  • DEVICE Route 92 Medical Reperfusion Systems

Study Locations (1)

Utah

  • Route 92 Medical, Inc. - West Jordan

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2026-02-12
Est. Completion 2029-11-30
Phase Phase 4

Sponsor

Route 92 Medical

2 total trials

What the Registry Record Tells You About NCT07436156

The ClinicalTrials.gov registry entry for NCT07436156 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 332-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (51% higher). The listed sponsor is Route 92 Medical, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Route 92 Medical Reperfusion Systems is the first listed.

NCT07436156 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT07436156 about?

NCT07436156 is a clinical study titled "SUMMIT RISE Study of Acute Ischemic Stroke Patients". SUMMIT RISE Study of Acute Ischemic Stroke Patients

What is the current status of trial NCT07436156?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 500 participants. The study started on 2026-02-12. Estimated completion is 2029-11-30.

What conditions does trial NCT07436156 study?

This clinical trial studies the following conditions: Acute Ischemic Stroke.

What interventions are being tested in trial NCT07436156?

The interventions under investigation include: Route 92 Medical Reperfusion Systems (DEVICE).

Who is sponsoring clinical trial NCT07436156?

This trial is sponsored by Route 92 Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07436156 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.